Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
Phase 1 Recruiting
20 enrolled
Lithium
Phase 1 Terminated
2 enrolled
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Phase 1 Completed
279 enrolled
A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors
Phase 1 Completed
23 enrolled
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
Phase 1 Completed
46 enrolled
GEN602
Phase 1 Unknown
127 enrolled
Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer
Phase 1 Completed
22 enrolled 6 charts
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Phase 1 Completed
30 enrolled
A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer
Phase 1 Completed
18 enrolled 13 charts
Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer
Phase 1 Terminated
3 enrolled
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
Phase 1 Terminated
16 enrolled
Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer
Phase 1 Completed
22 enrolled 20 charts
Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer
Phase 1 Completed
38 enrolled
Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer
Phase 1 Completed
76 enrolled 40 charts
Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients
Phase 1 Completed
14 enrolled
Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed